Acadian Asset Management LLC Kezar Life Sciences, Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 1,577,123 shares of KZR stock, worth $11.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,577,123
Previous 1,855,194 14.99%
Holding current value
$11.9 Million
Previous $1.11 Million 9.53%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$0.53 - $0.77 $147,377 - $214,114
-278,071 Reduced 14.99%
1,577,123 $1.22 Million
Q2 2024

Aug 06, 2024
BUY
$0.6 - $0.92 $38,613 - $59,207
64,356 Added 3.59%
1,855,194 $1.11 Million
Q1 2024

May 10, 2024
BUY
$0.8 - $1.05 $427,362 - $560,913
534,203 Added 42.51%
1,790,838 $1.61 Million
Q4 2023

Feb 13, 2024
BUY
$0.72 - $1.15 $305,958 - $488,683
424,942 Added 51.09%
1,256,635 $1.19 Million
Q3 2023

Nov 13, 2023
BUY
$1.08 - $2.54 $576,460 - $1.36 Million
533,760 Added 179.15%
831,693 $988,000
Q2 2023

Aug 07, 2023
BUY
$2.31 - $3.06 $654,693 - $867,256
283,417 Added 1952.45%
297,933 $729,000
Q1 2023

May 11, 2023
BUY
$3.13 - $7.31 $45,435 - $106,111
14,516 New
14,516 $45,000
Q2 2022

Aug 09, 2022
BUY
$4.58 - $17.13 $387,394 - $1.45 Million
84,584 New
84,584 $700,000
Q1 2022

May 12, 2022
SELL
$12.3 - $18.33 $3.19 Million - $4.75 Million
-258,946 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$7.44 - $16.72 $628,337 - $1.41 Million
-84,454 Reduced 24.59%
258,946 $4.33 Million
Q3 2021

Nov 12, 2021
BUY
$4.85 - $9.73 $33,159 - $66,524
6,837 Added 2.03%
343,400 $2.97 Million
Q1 2021

May 11, 2021
BUY
$5.24 - $6.99 $51,194 - $68,292
9,770 Added 2.99%
336,563 $2.01 Million
Q4 2020

Feb 11, 2021
BUY
$4.77 - $6.58 $171,352 - $236,373
35,923 Added 12.35%
326,793 $1.71 Million
Q3 2020

Nov 09, 2020
BUY
$4.36 - $5.5 $320,351 - $404,112
73,475 Added 33.8%
290,870 $1.41 Million
Q2 2020

Aug 12, 2020
BUY
$3.6 - $7.75 $210,636 - $453,452
58,510 Added 36.83%
217,395 $1.13 Million
Q1 2020

May 11, 2020
BUY
$2.77 - $5.75 $103,085 - $213,986
37,215 Added 30.59%
158,885 $693,000
Q4 2019

Feb 06, 2020
BUY
$2.5 - $4.26 $171,740 - $292,644
68,696 Added 129.68%
121,670 $488,000
Q3 2019

Nov 07, 2019
BUY
$3.0 - $7.58 $117,423 - $296,688
39,141 Added 282.95%
52,974 $174,000
Q2 2019

Aug 08, 2019
BUY
$7.09 - $21.9 $98,075 - $302,942
13,833 New
13,833 $107,000

Others Institutions Holding KZR

# of Institutions
63
Shares Held
39.1M
Call Options Held
13.8K
Put Options Held
600
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $514M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email